CTAS Stock Tickeron detected bullish Stock Pattern: Wedge Rising CTAS on December 22, 2025, netting in a 2.29% gain over 3 weeks

GET DAILY SIGNALS

Get AI intraday signals

CTAS - Cintas Corp

Ticker: CTAS

Company: Cintas

Gain: +2.29%

Confirmed: 12/22/25

Succeeded: 01/14/26

Total length: 27 days

On December 18, 2025, A.I.dvisor detected a Wedge Rising Pattern (Bullish) for Cintas Corp (CTAS, $189.89). On December 22, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $196.80. 23 days later, on January 14, 2026, CTAS reached the target price resulting in a for traders who took a long position in the stock.

CTAS sees its Stochastic Oscillator climbs out of oversold territory

On February 03, 2026, the Stochastic Oscillator for CTAS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 51 instances where the indicator left the oversold zone. In of the 51 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Technical Analysis (Indicators)

Bullish Trend Analysis

CTAS moved above its 50-day moving average on January 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTAS advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

CTAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 347 cases where CTAS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTAS as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CTAS turned negative on January 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTAS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTAS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.123) is normal, around the industry mean (14.577). P/E Ratio (41.284) is within average values for comparable stocks, (64.764). Projected Growth (PEG Ratio) (3.111) is also within normal values, averaging (2.307). Dividend Yield (0.009) settles around the average of (0.044) among similar stocks. P/S Ratio (7.225) is also within normal values, averaging (8.398).